Medications for obesity management: effectiveness and value
Atlas SJ, Kim K, Beinfeld M, Lancaster V, Nhan E, Lien PW, Shah K, Touchette DR, Moradi A, Rind DM, Pearson SD, Beaudoin, FL
Record ID 32018005188
English
Details
Project Status:
Completed
Year Published:
2022
URL for published report:
https://icer.org/wp-content/uploads/2022/03/ICER_Obesity_Final_Evidence_Report_and_Meeting_Summary_102022.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Obesity
- Anti-Obesity Agents
- Obesity, Morbid
- Liraglutide
- Bupropion
- Naltrexone
- Phentermine
- Topiramate
- Cost-Effectiveness Analysis
- Weight Loss
- Glucagon-Like Peptides
Contact
Organisation Name:
Institute for Clinical and Economic Review
Contact Address:
101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name:
info@icer-review.org
Contact Email:
info@icer-review.org
Copyright:
<p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.